Physician profile
Bob B Kiaii
NPI 1700423282
$195,053.08
in general payments reported to CMS, 2019-2025
26 companies · $37K in 2025
The $37K reported for 2025 was more than what 96% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2020: $16K · 2021: $20K · 2022: $49K · 2023: $52K · 2024: $22K · 2025: $37K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $93K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,325 · Travel and Lodging: $6,343 · Food and Beverage: $3,219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $92,652.78 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,325.00 |
| Travel and Lodging | $6,343.15 |
| Food and Beverage | $3,219.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $62,102.10 | 2020-2025 | Dermabond, Prolene, Ethibond Excel |
| Medical Device Business Services, INC. | $46,264.14 | 2021-2025 | Vistaseal, Echelon Flex, Enseal X1 |
| Medtronic, INC. | $33,634.94 | 2021-2025 | Simulus, Cg Future, Octopus |
| Ethicon US, LLC | $30,745.94 | 2022-2025 | Prolene, Surgicel Nu-Knit, Dermabond |
| Medtronic Vascular, INC. | $12,474.85 | 2020 | |
| Corcym INC | $2,559.94 | 2022-2025 | Perceval, Mi Detach - Aortic Cross Clamp - Delivery System Kit |
| Ethicon Endo-Surgery INC. | $2,160.00 | 2022 | |
| Livanova USA, INC. | $1,049.62 | 2019-2021 | |
| Lsi Solutions INC | $988.62 | 2019-2023 | Cor Knot |
| Abbott Laboratories | $869.95 | 2020-2023 | Mitraclip |
| Edwards Lifesciences Corporation | $544.61 | 2021-2023 | |
| Quest Medical INC. | $258.06 | 2020 | |
| Medistim USA, INC. | $240.23 | 2021-2022 | |
| Baxter Healthcare | $192.12 | 2022-2024 | Preveleak, Floseal |
| Abiomed | $181.66 | 2021-2023 | Impella |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Artivion, INC. | $162.68 | 2023 | Cardiac Non-Synergraft, Bioglue Surgical Adhesive, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder |
| Atricure, INC. | $126.27 | 2022 | |
| Cook Medical LLC | $110.71 | 2020 | |
| La Jolla Pharmaceutical Company | $80.15 | 2023 | Giapreza |
| Dilon Technologies, INC. | $72.17 | 2023-2024 | Hemoblast Bellows |
| Biom'Up France Sas | $52.91 | 2020 | |
| Terumo Cardiovascular Systems Corporation | $49.94 | 2022 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $49.03 | 2025 | |
| W. L. Gore & Associates, INC. | $33.39 | 2021 | |
| Kls-Martin L.P. | $29.99 | 2021 | |
| Medicaroid, INC. | $19.06 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bob Kiaii listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.